MoneyWorks4Me

Caplin Point Laboratories informs about press release

01 Jan 2026 Evaluate

Caplin Point Laboratories has informed that it enclosed a Press Release regarding acquisition of ten approved Abbreviated New Drug Applications (ANDAs) for Injectable and Opthalmic products from a leading Multinational Generic product manufacturing company.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1760.95
Dr. Reddys Labs. 1222.00
Cipla 1326.00
Lupin 1980.00
Zydus Lifesciences 1145.00
View more..